VANGUARD GROUP INC - 30 Sep 2025 SCHEDULE 13G/A Report for Heron Therapeutics Inc Common Stock (HRTX)

Filing Manager: VANGUARD GROUP INC
Reporting Manager: The Vanguard Group
Security: Heron Therapeutics Inc Common Stock
Symbol: HRTX
Shares outstanding: 183,509,414 shares
Disclosed Ownership: 8,459,784 shares
Ownership: 4.61%
Form type: SCHEDULE 13G/A
Filing time: 30 Oct 2025, 15:16:56 UTC
Date of event: 30 Sep 2025
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
The Vanguard Group	4.61%	8,459,784	0	917,424	Ashley Grim	Head of Global Fund Administration